Conference Roundup

AAAI Cancels Annual Meeting

Posted on

The American Academy of Allergy, Asthma & Immunology (AAAAI) announced they have decided to cancel the 2020 Annual Meeting scheduled to take place March 13-16 in Philadelphia due to the evolving situation with the coronavirus disease 2019 (COVID-19).

“Cancelling the 2020 AAAAI Annual Meeting was a difficult decision made by the AAAAI Board of Directors after careful thought and deliberation,” said AAAAI President David M. Lang, MD, FAAAAI in the announcement. “While an incredible amount of work went into planning this year’s educational program, and all of our speakers and abstract authors have put immense time and energy into their presentations and posters, it has reached a point with COVID-19 where the AAAAI felt it was absolutely necessary to cancel the Annual Meeting in order to protect the health and safety of attendees.”

Read the full announcement here

Related Articles
New Opsumit (macitentan) Data Show Initial Combination Therapy with Tadalafil Improved Hemodynamic Clinical and Functional Parameters in Patients with Pulmonary Arterial Hypertension
May 31, 2020
FDA Approves First Treatment for Chronic Fibrosing ILDs with Progressive Phenotype
Mar 16, 2020
Inhaled Nitric Oxide Improves Physical Activity Iin Patients with Pulmonary Fibrosis At-risk for Pulmonary Hypertension
Mar 11, 2020